A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Effect of MK-1167 on QTc in Healthy Adult Participants

The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

The key inclusion criteria but are not limited to the following:

• Is in good health
• Has a body mass index (BMI) ≥18 and ≤32 kg/m^2, inclusive

The key inclusion criteria but are not limited to the following:

• Has a history of clinically significant endocrine, gastrointestinal, cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological abnormalities or diseases
• Is a smoker and/or has used nicotine or nicotine-containing products (for example, nicotine patch and electronic cigarette) within the past 3 months